How many clinical trials are tracked for Dengue Hemorrhagic Fever?

24 trials are tracked, 5 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Dengue Hemorrhagic Fever

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Dengue Hemorrhagic Fever

24 trials tracked for Dengue Hemorrhagic Fever: 8 in phase 3 or 4 and 5 with published results. The most-cited published study has 1074 citations.

24Trials tracked

8Phase 3 & 4

0Recruiting

5With published results

Phase distribution

Phase 3 8 Phase 2 15 Other / NA 1

Phase 3 Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America Completed · 1,074 cited
Phase 3 Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia Completed · 49 cited
Phase 3 Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia Completed · 27 cited
Phase 3 Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix® Completed · 7 cited
Phase 3 Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil® Completed · 6 cited
Phase 3 Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers Completed

Show 18 more trials

Phase 3 Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers Completed
Phase 3 Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia Completed
Phase 2 Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule Completed
Phase 2 Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule Completed
Phase 2 Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore Completed
Phase 2 Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America Completed
Phase 2 Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America Completed
Phase 2 Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US Completed
Phase 2 Efficacy and Safety of Dengue Vaccine in Healthy Children Completed
Phase 2 Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India Completed
Phase 2 Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age Completed
Phase 2 Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects Completed
Phase 2 A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children Completed
Phase 2 Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years Completed
Phase 2 Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine Completed
Phase 2 Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults Completed
Phase 2 Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine Completed
N/A Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study Completed

Showing the 24 most-cited and recently-updated of 24 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.